Literature DB >> 34762459

Antiviral pills could change pandemic's course.

Jennifer Couzin-Frankel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34762459     DOI: 10.1126/science.acx9605

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  22 in total

Review 1.  Paxlovid: Mechanism of Action, Synthesis, and In Silico Study.

Authors:  Mahrokh Marzi; Mohammad Kazem Vakil; Maryam Bahmanyar; Elham Zarenezhad
Journal:  Biomed Res Int       Date:  2022-07-07       Impact factor: 3.246

Review 2.  Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19.

Authors:  Stephani C Wang; Fengmin Zhang; Hui Zhu; Haipeng Yang; Yang Liu; Ping Wang; Vladimir Parpura; Yu-Feng Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

3.  Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial.

Authors:  Miguel Cervero; Daniel López-Wolf; Guiomar Casado; Maria Novella-Mena; Pablo Ryan-Murua; María Luisa Taboada-Martínez; Sara Rodríguez-Mora; Lorena Vigón; Mayte Coiras; Montserrat Torres
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

Review 4.  Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19.

Authors:  Chengyu Liu; Wanyao Yan; Jiajian Shi; Shun Wang; Anlin Peng; Yuchen Chen; Kun Huang
Journal:  Front Nutr       Date:  2022-06-22

Review 5.  Probiotics for the Management of Infectious Diseases: Reviewing the State of the Art.

Authors:  Cato Wiegers; Linda H M van de Burgwal; Olaf F A Larsen
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 6.064

Review 6.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

7.  High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.

Authors:  Dora Buonfrate; Fabio Chesini; Davide Martini; Maria Carla Roncaglioni; Maria Luisa Ojeda Fernandez; Maria Francesca Alvisi; Irene De Simone; Eliana Rulli; Alessandro Nobili; Giacomo Casalini; Spinello Antinori; Marco Gobbi; Caterina Campoli; Michela Deiana; Elena Pomari; Gianluigi Lunardi; Roberto Tessari; Zeno Bisoffi
Journal:  Int J Antimicrob Agents       Date:  2022-01-06       Impact factor: 5.283

Review 8.  COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.

Authors:  Lindsey Wang; David C Kaelber; Rong Xu; Nathan A Berger
Journal:  Blood Rev       Date:  2022-01-31       Impact factor: 10.626

9.  Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Authors:  Yuan-Pin Hung; Jen-Chieh Lee; Chun-Wei Chiu; Ching-Chi Lee; Pei-Jane Tsai; I-Lin Hsu; Wen-Chien Ko
Journal:  Antibiotics (Basel)       Date:  2022-02-09

10.  The Petasites hybridus CO2 Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro.

Authors:  Lorena Urda; Matthias Heinrich Kreuter; Jürgen Drewe; Georg Boonen; Veronika Butterweck; Thomas Klimkait
Journal:  Viruses       Date:  2022-01-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.